[1]奚云萍 臧雁翔 李为民.临床SYNTAX计分及其衍生计分在冠心病血运重建预后中的应用价值[J].心血管病学进展,2020,(5):452-455.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
　XI Yunping,ZANG Yanxiang,LI Weimin.Value of Clinical SYNTAX Score and Its Derivative Score in Prognosis of Coronary Artery Disease with Revascularization[J].Advances in Cardiovascular Diseases,2020,(5):452-455.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.004]
点击复制

临床SYNTAX计分及其衍生计分在冠心病血运重建预后中的应用价值()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2020年5期
页码:
452-455
栏目:
出版日期:
2020-05-25

文章信息/Info

Title:
Value of Clinical SYNTAX Score and Its Derivative Score in Prognosis of Coronary Artery Disease with Revascularization
作者:
奚云萍1; 2 臧雁翔 1; 2 李为民2
(1.哈尔滨医科大学研究生院,黑龙江 哈尔滨 150000;2.哈尔滨医科大学附属第一医院心内科,黑龙江 哈尔滨 150001)
Author(s):
XI Yunping1; ZANG Yanxiang1;  LI Weimin 1; 2
(1.Harbin Medical University Graduate School,Harbin 150000,Heilongjiang,China; 2.Department of Cardiology, The First Affiliated Hospital of Harbin Medical University ,Harbin 150001,Heilongjiang,China)
关键词:
临床SYNTAX计分; 冠状动脉粥样硬化性心脏病; 经皮冠脉介入术; 冠状动脉旁路移植术; 预后
Keywords:
Clinical SYNTAX score;  Coronary heart disease;  Percutaneous coronary intervention;  Coronary artery bypass grafting
DOI:
10.16806/j.cnki.issn.1004-3934.2020.05.004
摘要:
冠状动脉粥样硬化性心脏病的不良预后常与冠状动脉复杂病变相关，而冠状动脉病变程度的评估在临床中经常应用冠状动脉造影计算。其中SYNTAX计分是一种基于冠状动脉病变的复杂性和严重性来指导治疗决策的计分系统，并且预测冠状动脉粥样硬化性心脏病患者的临床预后。但因SYNTAX计分只涉及解剖因素，对于预后有重要影响的临床因素却未纳入，降低了其预测能力，因此，在其基础上提出了临床SYNTAX计分的概念，现就该计分研究进展和临床应用进行综述。
Abstract:
The adverse prognosis of coronary artery disease is often associated with complex coronary lesions, and coronary angiography is often used to evaluate the severity of coronary lesions. Among them, SYNTAX score is a scoring system that guides the decision based on the complexity and severity of coronary artery lesions, and predicts the clinical prognosis of patients with coronary heart disease. However, SYNTAX score only involves anatomical factors, but clinical factors that have important influence on prognosis are not included, which greatly reduces its prediction ability. Therefore, the concept of clinical SYNTAX score is proposed on the basis of SYNTAX score. This article will review the research progress and clinical application of SYNTAX score

相似文献/References:

[1]赵丹 周鹏.达比加群及其逆转剂在心血管疾病中的研究进展[J].心血管病学进展,2019,(5):801.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.034]
　ZHAO DanZHOU Peng.Dabigatran and Reversal in Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(5):801.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.034]
[2]陈元 楚天舒 武力勇.瘦素抵抗、瘦素受体基因多态性与冠状动脉粥样硬化性心脏病的相关性进展[J].心血管病学进展,2019,(8):1130.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.015]
　CHEN Yuan,CHU Tianshu,WU Liyong.Leptin Resistance,Leptin Receptor Gene Polymorphism and Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(5):1130.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.015]
[3]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
　SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(5):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[4]孙涛 左权 周辉 刘安康 梁诚 汤圣兴.末梢桡动脉和无鞘技术在冠状动脉介入治疗中的应用现状[J].心血管病学进展,2020,(5):456.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.005]
[5]肖亚楠 高传玉 朱中玉.低剂量替格瑞洛在冠心病中的应用前景[J].心血管病学进展,2020,(7):706.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.009]
　XIAO Yanan,GAO Chuanyu,ZHU Zhongyu.Application Prospects of Low-dose Ticagrelor in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2020,(5):706.[doi:10.16806/j.cnki.issn.1004-3934.2020.07.009]
[6]史云聪,王立立 郭艺芳.维生素D与心血管疾病相关性研究进展[J].心血管病学进展,2020,(8):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
　SHI YuncongWANG LiliGUO Yifang.Vitamin D And Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2020,(5):826.[doi:10.16806/j.cnki.issn.1004-3934.20.08.011]
[7]李英  刘兴鹏.常见心血管病服药依从性[J].心血管病学进展,2020,(10):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
　LI Ying,LIU Xingpeng.Medication Adherence For Common Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2020,(5):1016.[doi:10.16806/j.cnki.issn.1004-3934.2020.10.000]
[8]肖亚楠 高传玉.经皮冠脉介入术后短程双联抗血小板治疗的研究进展[J].心血管病学进展,2021,(4):318.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.008]
　XIAO Yanan,GAO Chuanyu.Short-term Dual Antiplatelet Therapy after Percutaneous Coronary Intervention[J].Advances in Cardiovascular Diseases,2021,(5):318.[doi:10.16806/j.cnki.issn.1004-3934.2021.04.008]
[9]吉蓉 寿锡凌.秋水仙碱在冠状动脉粥样硬化性心脏病防治中的研究进展与争议[J].心血管病学进展,2022,(1):60.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.016]
　JI Rong,SHOU Xiling.Research Progress and Controversy of Colchicine in Prevention and Treatment of Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2022,(5):60.[doi:10.16806/j.cnki.issn.1004-3934.2022.01.016]
[10]赵攀果 黄毅雄 肖丽苹 李田昌.基于声学理论检测冠心病的新方法[J].心血管病学进展,2022,(12):1068.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.003]
　ZHAO PanguoHUANG YixiongXIAO LipingLI Tianchang.A New Method for the Diagnosis of Coronary Artery Disease Based on Acoustic Theory[J].Advances in Cardiovascular Diseases,2022,(5):1068.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.003]

更新日期/Last Update: 2020-08-12